VLA-4 antagonists

Details for Australian Patent Application No. 2005222074 (hide)

International Classifications

Event Publications

21 September 2006 PCT application entered the National Phase

PCT publication WO2005/087760 Priority application(s): WO2005/087760

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

17 February 2011 Application Accepted

Published as AU-B-2005222074

16 June 2011 Standard Patent Sealed

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.